Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
about
Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.Oral cyclosporine treatment in dogs: a review of the literature.CypA, a gene downstream of HIF-1α, promotes the development of PDACGeneric-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin.
P2860
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
@ast
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
@en
type
label
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
@ast
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
@en
prefLabel
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
@ast
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
@en
P2860
P356
P1476
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
@en
P2093
S S Narsipur
P2860
P304
P356
10.1155/2011/480642
P577
2011-11-17T00:00:00Z